Works by Wolach, Ofir

Results: 71
    1
    2

    MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin Level.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 18, p. 5865, doi. 10.3390/jcm12185865
    By:
    • Haring, Yael;
    • Goldschmidt, Noa;
    • Taha, Shaimaa;
    • Stemer, Galia;
    • Filanovsky, Kalman;
    • Hellman, Ilana;
    • Okasha, Doaa;
    • Krayem, Baher;
    • Levi, Itai;
    • Rosenbaum, Hanna;
    • Koren-Michowitz, Maya;
    • Yagna, Shai;
    • Nemets, Anatoly;
    • Gino-Moor, Sharon;
    • Saban, Revital;
    • Cohen, Joseph;
    • Halperin, Erez;
    • Wolach, Ofir;
    • Dally, Najib;
    • Merkel, Drorit
    Publication type:
    Article
    3
    4

    Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 4, p. 615, doi. 10.1002/ajh.27246
    By:
    • Pratz, Keith W.;
    • Jonas, Brian A.;
    • Pullarkat, Vinod;
    • Thirman, Michael J.;
    • Garcia, Jacqueline S.;
    • Döhner, Hartmut;
    • Récher, Christian;
    • Fiedler, Walter;
    • Yamamoto, Kazuhito;
    • Wang, Jianxiang;
    • Yoon, Sung‐Soo;
    • Wolach, Ofir;
    • Yeh, Su‐Peng;
    • Leber, Brian;
    • Esteve, Jordi;
    • Mayer, Jiri;
    • Porkka, Kimmo;
    • Illés, Árpád;
    • Lemoli, Roberto M.;
    • Turgut, Mehmet
    Publication type:
    Article
    5

    Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 7, p. 790, doi. 10.1002/ajh.26190
    By:
    • Apel, Arie;
    • Moshe, Yakir;
    • Ofran, Yishai;
    • Gural, Alexander;
    • Wolach, Ofir;
    • Ganzel, Chezi;
    • Canaani, Jonathan;
    • Zektser, Miri;
    • Duek, Adrian;
    • Stemer, Galia;
    • Hellman, Ilana;
    • Basood, May;
    • Frisch, Avraham;
    • Leibovitch, Chiya;
    • Koren‐Michowitz, Maya
    Publication type:
    Article
    6
    7

    Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: Randomized controlled trial.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 3, p. 243, doi. 10.1002/ajh.23622
    By:
    • Paul, Mical;
    • Ram, Ron;
    • Kugler, Eitan;
    • Farbman, Laura;
    • Peck, Anat;
    • Leibovici, Leonard;
    • Lahav, Meir;
    • Yeshurun, Moshe;
    • Shpilberg, Ofer;
    • Herscovici, Corina;
    • Wolach, Ofir;
    • Itchaki, Gilad;
    • Bar-Natan, Michal;
    • Vidal, Liat;
    • Gafter-Gvili, Anat;
    • Raanani, Pia
    Publication type:
    Article
    8
    9

    Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B-cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia.

    Published in:
    2019
    By:
    • Elitzur, Sarah;
    • Arad‐Cohen, Nira;
    • Barzilai‐Birenboim, Shlomit;
    • Ben‐Harush, Miriam;
    • Bielorai, Bella;
    • Elhasid, Ronit;
    • Feuerstein, Tamar;
    • Gilad, Gil;
    • Gural, Alexander;
    • Kharit, Mira;
    • Litichever, Naomi;
    • Nirel, Ronit;
    • Weinreb, Sigal;
    • Wolach, Ofir;
    • Toren, Amos;
    • Izraeli, Shai;
    • Jacoby, Elad;
    • Arad-Cohen, Nira;
    • Barzilai-Birenboim, Shlomit;
    • Ben-Harush, Miriam
    Publication type:
    journal article
    10
    11
    12
    13
    14

    Venetoclax is safe and efficacious in relapsed/refractory AML.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 9, p. 2221, doi. 10.1080/10428194.2020.1761964
    By:
    • Ganzel, Chezi;
    • Ram, Ron;
    • Gural, Alexander;
    • Wolach, Ofir;
    • Gino-Moor, Sharon;
    • Vainstein, Vladimir;
    • Nachmias, Boaz;
    • Apel, Arie;
    • Koren-Michowitz, Maya;
    • Pasvolsky, Oren;
    • Yerushalmi, Ronit;
    • Danylesko, Ivetta;
    • Cohen, Yosef;
    • Peretz, Galit;
    • Moshe, Yakir;
    • Zektser, Miri;
    • Yeganeh, Shay;
    • Rowe, Jacob M.;
    • Ofran, Yishai
    Publication type:
    Article
    15
    16
    17

    A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 24, p. 3905, doi. 10.1002/cncr.34985
    By:
    • Bairey, Osnat;
    • Taliansky, Alisa;
    • Glik, Amir;
    • Amiel, Alexandra;
    • Yust‐Katz, Shlomit;
    • Gurion, Ronit;
    • Zektser, Miri;
    • Porges, Tzvika;
    • Sarid, Nadav;
    • Horowitz, Netanel A.;
    • Shina, Tzahala Tzuk;
    • Lebel, Eyal;
    • Cohen, Amos;
    • Geiger, Karyn Revital;
    • Raanani, Pia;
    • Wolach, Ofir;
    • Siegal, Tali
    Publication type:
    Article
    18
    19
    20

    Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 436, p. 1, doi. 10.1126/scitranslmed.aan8292
    By:
    • Wolach, Ofir;
    • Sellar, Rob S.;
    • Martinod, Kimberly;
    • Cherpokova, Deya;
    • McConkey, Marie;
    • Chappell, Ryan J.;
    • Silver, Alexander J.;
    • Adams, Dylan;
    • Castellano, Cecilia A.;
    • Schneider, Rebekka K.;
    • Padera, Robert F.;
    • DeAngelo, Daniel J.;
    • Wadleigh, Martha;
    • Steensma, David P.;
    • Galinsky, Ilene;
    • Stone, Richard M.;
    • Genovese, Giulio;
    • McCarroll, Steven A.;
    • Iliadou, Bozenna;
    • Hultman, Christina
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50